Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 12Completed 7Not yet recruiting 6Terminated 5Unknown 3Enrolling by invitation 1Approved for marketing 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Sarcoma 1

Conditions

Osteosarcoma 1NSCLC 1Advanced Squamous Non-Small-Cell Lung Cancer 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × trilaciclib × Clear all
NCT06328049 2024-03-25

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC

Taixing People's Hospital

Phase 2 Unknown
30 enrolled
Thoracic

NSCLC

NCT06217003 2024-01-22

Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma

The First Affiliated Hospital of Xinxiang Medical College

Phase 2 Unknown
20 enrolled
Sarcoma

Osteosarcoma

NCT05900921 2023-06-13

Trilaciclib Prior to Chemotherapy Plus Tislelizumab as 1L Treatment for Advanced Squamous Non-Small-Cell Lung Cancer

Sichuan University

Phase 2 Unknown
132 enrolled
Thoracic

Advanced Squamous Non-Small-Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡